Yajuan Chen
Key Laboratory Of Breast Cancer Precision Medicine
Kunming, China
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
In situ generation of proinflammatory CAR macrophages via mRNA-TLR agonist co-delivery for triple-negative breast cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 14, 2026
A dual-responsive self-healing injectable hydrogel loaded with Isatis root-derived carbon dots toward efficient infected wound therapy.
Journal: International journal of biological macromolecules
Published: April 16, 2026
FAM111B may promote the progression of lung squamous cell carcinoma through PI3K signaling pathway.
Journal: Scientific reports
Published: February 26, 2026
Regulation of Trichoderma harzianum gene expression and protein production in submerged cultures with inactivated oomycete mycelium.
Journal: Microbiological research
Published: January 06, 2025
A novel method for exploration and prediction of the bioactive target of rice bran-derived peptide (KF-8) by integrating computational methods and experiments.
Journal: Food & function
Published: November 12, 2024
Rice bran active peptide (RBAP) inhibited macrophage differentiation to foam cell and atherosclerosis in mice via regulating cholesterol efflux.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 09, 2024
9-Nitro-20(S)-carbonate-camptothecin (NCP4), a novel prodrug of 9-nitrocamptothecin (9-NC), exhibits potent chemotherapeutic efficacy and improved safety against hepatocarcinoma.
Journal: European journal of pharmacology
Published: October 24, 2021
Telomere length is maternally inherited and associated with lipid metabolism in Chinese population.
Journal: Aging
Published: June 24, 2021
Epidemiology characteristics of ethnic minority colorectal cancer in Yunnan in Southwestern China.
Journal: Translational cancer research
Published: October 04, 2019
miRNA-99b-5p targets FZD8 to inhibit non-small cell lung cancer proliferation, migration and invasion.
Journal: OncoTargets and therapy
Published: May 02, 2019
Last Updated: 09/26/2026